These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19161869)

  • 1. Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple.
    Von Kohorn I; Ehrenkranz RA
    Clin Perinatol; 2009 Mar; 36(1):111-23. PubMed ID: 19161869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004868. PubMed ID: 22972077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher S; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004868. PubMed ID: 16856064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2012 Oct; 10():CD004865. PubMed ID: 23076909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity.
    Fain J; Hilsenrath P; Widness JA; Strauss RG; Mutnick AH
    Transfusion; 1995; 35(11):936-43. PubMed ID: 8604492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia of prematurity: progress and prospects.
    Shannon KM
    Am J Pediatr Hematol Oncol; 1990; 12(1):14-20. PubMed ID: 2178457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004863. PubMed ID: 24771408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
    Ohls RK; Christensen RD
    J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants.
    Tempera A; Stival E; Piastra M; De Luca D; Ottaviano C; Tramontozzi P; Marconi M; Cafforio C; Marcozzi P; Rossi N; Buffone E
    J Matern Fetal Neonatal Med; 2011 Aug; 24(8):1060-4. PubMed ID: 21250913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin in anemia of prematurity.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):80-4. PubMed ID: 23025776
    [No Abstract]   [Full Text] [Related]  

  • 16. Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants.
    Becquet O; Guyot D; Kuo P; Pawlotsky F; Besnard M; Papouin M; Lapillonne A
    BMC Pediatr; 2013 Oct; 13():176. PubMed ID: 24165292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin in anemia of prematurity.
    Whitehall JS; Patole SK; Campbell P
    Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic growth factors: Part II.
    Wandstrat TL; Wolfe M
    Neonatal Netw; 1996 Oct; 15(7):25-8. PubMed ID: 9035641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial impact of the introduction of erythropoietin in the treatment of anemia of premature infants in Israel.
    Dollberg S; Mimouni FB
    Isr Med Assoc J; 1999 Oct; 1(2):86-8. PubMed ID: 10731302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.